METHOD AND APPARATUS FOR MAXIMIZING QUANTITY OF BLOOD PULSATED OUT FROM HEART BY KEEPING PACE OF ATRIUM BY USING CARDIAC DIFIBRILLATION DEVICE/ PACER

• 1. 心房分流减压装置及心房分流减压装置使用编制装置 [P] . 中国专利： CN210962104U . 2020.07.10
• 2. 使用心音检测心房心律失常 [P] . 中国专利： CN108471968B . 2022.01.18
• 3. Methods and apparatus for preventing atrial arrhythmias by overdrive pacing multiple heart tissue sites using an implantable cardiac stimulation device [P] . 美国专利： US7103411B1 . 2006-09-05

  机译： 通过使用植入式心脏刺激装置过速起搏多个心脏组织部位来预防房性心律失常的方法和装置

• 4. Methods and apparatus for overdrive pacing heart tissue using an implantable cardiac stimulation device [P] . 美国专利： US7043302B1 . 2006-05-09

  机译： 使用植入式心脏刺激装置使心脏组织起搏过速的方法和装置

• 5. Methods and apparatus for overdrive pacing heart tissue using an implantable cardiac stimulation device [P] . 美国专利： US6990374B1 . 2006-01-24

  机译： 使用植入式心脏刺激装置使心脏组织起搏过速的方法和装置

• 1. Heart Closed-Loop Model for the Assessment of Cardiac Pacing [C] . Niccolo Biasi, Alessandro Tognetti Mediterranean Conference on Medical and Biological Engineering and Computing . 2020
• 2. Electrocardiographic imaging of paced sequences and infarct substrate in canine hearts, and in patients undergoing cardiac resynchronization therapy. [D] . Jia, Ping. 2004
• 3. Implantable Cardiac Pacing Devices Related Complications: Keeping Pace With Time [O] . Shomu Bohora 2011
• 4. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines) 11This document was approved by the American College of Cardiology Foundation Board of Trustees in September 2002, the American Heart Association Science Advisory and Coordinating Committee in August 2002, and the North American Society for Pacing and Electrophysiology in August 2002.22The ACC/AHA Task Force on Practice Guidelines makes every effort to avoid any actual or potential conflicts of interest that might arise as a result of an outside relationship or personal interest of a member of the writing panel. Specifically, all members of the writing panel are asked to provide disclosure statements of all such relationships that might be perceived as real or potential conflicts of interest. These statements are reviewed by the parent task force, reported orally to all members of the writing panel at the first meeting, and updated as changes occur. The conflict of interest information for the writing committee members is posted on the ACC, AHA, and NASPE Web sites with the full-length version of the update.33When citing this document, the ACC, the AHA, and NASPE would appreciate the following citation format: Gregoratos G, Abrams J, Epstein AE, Freedman RA, Hayes DL, Hlatky MA, Kerber RE, Naccarelli GV, Schoenfeld MH, Silka MJ, Winters SL. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol2002;40:1703–19.44Copies: This document is available on the World Wide Web sites of the ACC (www.acc.org) and the AHA (www.americanheart.org). A single copy of the complete guidelines is available by calling 800-253-4636 (US only) or writing the American College of Cardiology, Resource Center, 9111 Old Georgetown Road, Bethesda, MD 20814-1699 (ask for No. 71-0237). To obtain a copy of the Summary Article, ask for reprint No. 71-0236. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail kbradle@lww.com.55(J Am Coll Cardiol 2002;40:1703–19.)66©2002 by the American College of Cardiology Foundation and the American Heart Association, Inc. [O] . Gregoratos Gabriel, Abrams Jonathan, Epstein Andrew E, 2002
• 5. Optimizing Cardiac Resynchronization Therapy in Heart Failure Patients by Measuring Transient Changes in Sinus Rate During Pacing. [R] . Baumann, L., Kadhiresan, V., Yinghong, Y., 2001

• 1. Predictors of super-response to cardiac resynchronization therapy： the significance of heart failure medication, pre-implant left ventricular geometry and high percentage of biventricular pacing [J] . Han JIN ,Min GU ,Wei HUA . 老年心脏病学杂志：英文版 . 2017,第12期
• 2. IN VIVO CHARACTERIZATION OF ATTACHMENT SAFETY BETWEEN CARDIAC PACING LEAD AND CANINE HEART MUSCLE [J] . Zhang Xiangming ,Niu Guodong ,Ma Nianke . 固体力学学报：英文版 . 2007,第3期
• 3. Study on Apoptosis and Expression of P53, Bcl-2, Bax in Cardiac Myocytys of Congestive Heart Failure Induced by Ventricular Pacing [J] . QI Benling ,CAO Linsheng ,WANG Lin . 华中科技大学学报（医学）（英德文版） . 2001,第003期
• 4. Study on Apoptosis and Expression of P53, Bcl-2, Bax in Cardiac Myocytys of Congestive Heart Failure Induced by Ventricular Pacing [J] . QI ,Benling ,CAO . 华中科技大学学报：医学英德文版 . 2001,第003期
• 5. 组织及血流多普勒联合心尖搏动图评价心房颤动复律后心房顿抑和心房功能的临床研究 [C] . 刘岩 ,王珂 . 第八次全国心血管病学术会议 . 2004
• 6. 右美托咪定对大鼠离体搏动心房机械活动的影响 [A] . 于佳汝 . 2020